METFORMIN HCL ER 500 MG TABLET
For 30 tablets
Pharmacies pay
$0.85 filed
30 × $0.02838 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$1.80 filed
30 × $0.05999 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.1× estimated
Medicare paid 2.1× what pharmacies pay.
Part D averages every strength and form sold under “Metformin HCl ER” / “Metformin HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.98 estimated
$0.85 + $0.13 (15%) + $5.00 fee per fill = $5.98
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
METFORMIN HCL ER 500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “metformin hydrochloride” and “metformin er 500 mg”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “METFORMIN HYDROCHLORIDE ER”, “METFORMIN HYDROCHLORIDE EXTENDED RELEASE” and “Metformin”.
FDA gives its dosage form as “tablet, extended release” and “tablet” and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Unichem Pharmaceuticals (USA), Inc., Laurus Labs Limited and Epic Pharma, LLC.
FDA’s Established Pharmacologic Class for it is Biguanide.
The NADAC file of 2026-10-14 prices it under 31 NDCs (National Drug Codes); the FDA directory lists 30 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.85 for 30 tablets (30 × $0.02838 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Ascend Laboratories, LLC | 5 | $0.02838 per EA filed |
| Granules Pharmaceuticals Inc. | 4 | $0.02838 per EA filed |
| Laurus Labs Limited | 4 | $0.02838 per EA filed |
| TIME CAP LABORATORIES, INC | 4 | $0.02838 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 3 | $0.02838 per EA filed |
| Epic Pharma, LLC | 2 | $0.02838 per EA filed |
| Leading Pharma, LLC | 2 | $0.02838 per EA filed |
| Precision Dose, Inc. | 2 | $0.02838 per EA filed |
| Quallent Pharmaceuticals Health LLC | 2 | $0.02838 per EA filed |
| AvPAK | 1 | $0.02838 per EA filed |
| Legacy Pharmaceutical Packaging, LLC | 1 | $0.02838 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.02838 per EA filed |
All 31 NDCs, with labeler and price
- 29300-0389-01 · Unichem Pharmaceuticals (USA), Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 29300-0389-05 · Unichem Pharmaceuticals (USA), Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 42385-0977-01 · Laurus Labs Limited · $0.02838 per EA · eff. 2026-09-23 filed
- 42385-0977-05 · Laurus Labs Limited · $0.02838 per EA · eff. 2026-09-23 filed
- 42385-0977-11 · Laurus Labs Limited · $0.02838 per EA · eff. 2026-09-23 filed
- 42385-0977-90 · Laurus Labs Limited · $0.02838 per EA · eff. 2026-09-23 filed
- 42806-0632-01 · Epic Pharma, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 42806-0632-05 · Epic Pharma, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 49483-0623-01 · TIME CAP LABORATORIES, INC · $0.02838 per EA · eff. 2026-09-23 filed
- 49483-0623-09 · TIME CAP LABORATORIES, INC · $0.02838 per EA · eff. 2026-09-23 filed
- 49483-0623-10 · TIME CAP LABORATORIES, INC · $0.02838 per EA · eff. 2026-09-23 filed
- 49483-0623-50 · TIME CAP LABORATORIES, INC · $0.02838 per EA · eff. 2026-09-23 filed
- 50268-0550-11 · not listed as a package in the FDA directory · $0.02838 per EA · eff. 2026-09-23 filed
- 50268-0550-15 · AvPAK · $0.02838 per EA · eff. 2026-09-23 filed
- 67877-0159-01 · Ascend Laboratories, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 67877-0159-05 · Ascend Laboratories, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 67877-0413-01 · Ascend Laboratories, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 67877-0413-05 · Ascend Laboratories, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 67877-0413-90 · Ascend Laboratories, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 68094-0904-50 · Precision Dose, Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 68094-0904-60 · Precision Dose, Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 68645-0595-59 · Legacy Pharmaceutical Packaging, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 69315-0410-01 · Leading Pharma, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 69315-0410-05 · Leading Pharma, LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 70010-0491-01 · Granules Pharmaceuticals Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 70010-0491-05 · Granules Pharmaceuticals Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 70010-0491-09 · Granules Pharmaceuticals Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 70010-0491-10 · Granules Pharmaceuticals Inc. · $0.02838 per EA · eff. 2026-09-23 filed
- 76385-0128-10 · UNICHEM PHARMACEUTICALS (USA), INC. · $0.02838 per EA · eff. 2026-09-23 filed
- 82009-0117-10 · Quallent Pharmaceuticals Health LLC · $0.02838 per EA · eff. 2026-09-23 filed
- 82009-0180-05 · Quallent Pharmaceuticals Health LLC · $0.02838 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
11 other products in the NADAC file share an FDA nonproprietary name with METFORMIN HCL ER 500 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| METFORMIN ER 1,000 MG GASTR-TB | $0.3357 per EA filed | We don’t know yet |
| METFORMIN ER 1,000 MG OSM-TAB | $0.31418 per EA filed | $2.20305 per EA filed |
| METFORMIN ER 500 MG GASTRC-TB | $0.27102 per EA filed | We don’t know yet |
| METFORMIN ER 500 MG OSMOTIC TB | $0.1644 per EA filed | $2.20305 per EA filed |
| METFORMIN HCL 1,000 MG TABLET | $0.02315 per EA filed | $0.05643 per EA filed |
| METFORMIN HCL 500 MG TABLET | $0.01451 per EA filed | $0.05643 per EA filed |
| METFORMIN HCL 500 MG/5 ML SOLN | $0.3829 per ML filed | We don’t know yet |
| METFORMIN HCL 625 MG TABLET | $12.5266 per EA filed | $0.05643 per EA filed |
| METFORMIN HCL 750 MG TABLET | $14.605 per EA filed | $0.05643 per EA filed |
| METFORMIN HCL 850 MG TABLET | $0.02398 per EA filed | $0.05643 per EA filed |
| METFORMIN HCL ER 500 MG TABLET this page | $0.02838 per EA filed | $0.05999 per EA filed |
| METFORMIN HCL ER 750 MG TABLET | $0.05264 per EA filed | $0.05999 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 31 NDCs’ NADAC prices is $0.02838 per EA filed.
Of the 71 other products in FDA’s Biguanide class priced per EA, 68 have a higher middle NADAC price and 3 a lower one. The one in the middle is SYNJARDY XR 5-1,000 MG TABLET, at $5.61111 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $1.80 for 30 tablets, at an average of $0.05999 per EA in 2024 (2024-01-01 to 2024-12-31) for “Metformin HCl ER” and “Metformin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 10,256,666 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for METFORMIN HCL ER 500 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Metformin HCl ER / Metformin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- JANUMET 50-1,000 MG TABLET
- SYNJARDY XR 10-1,000 MG TABLET
- GLIPIZIDE-METFORMIN 2.5-250 MG
- SYNJARDY 12.5-1,000 MG TABLET
- TRIJARDY XR 10-5-1,000 MG TAB